These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 21985184

  • 1. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions.
    Kokolakis G, Giannikaki E, Stathopoulos E, Avramidis G, Tosca AD, Krüger-Krasagakis S.
    Br J Dermatol; 2012 Mar; 166(3):491-7. PubMed ID: 21985184
    [Abstract] [Full Text] [Related]

  • 2. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
    Krüger-Krasagakis S, Galanopoulos VK, Giannikaki L, Stefanidou M, Tosca AD.
    Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
    Markham T, Mathews C, Rogers S, Mullan R, Bresnihan B, Fitzgerald O, Veale DJ, Fearon U.
    Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388
    [Abstract] [Full Text] [Related]

  • 4. Nature of cell kinetics in psoriatic epidermis.
    Doger FK, Dikicioglu E, Ergin F, Unal E, Sendur N, Uslu M.
    J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
    [Abstract] [Full Text] [Related]

  • 5. Influence of infliximab on keratinocyte apoptosis in psoriasis patients.
    Raho G, Vena GA, Bizzoca A, Cassano N, Garofalo E, Congedo M, Gennarini G.
    Immunopharmacol Immunotoxicol; 2011 Mar; 33(1):227-31. PubMed ID: 20507213
    [Abstract] [Full Text] [Related]

  • 6. Apoptosis, P53 and Bcl-2 expression in response to topical calcipotriol therapy for psoriasis.
    El-Domyati M, Barakat M, Abdel-Razek R, El-Din Anbar T.
    Int J Dermatol; 2007 May; 46(5):468-74. PubMed ID: 17472673
    [Abstract] [Full Text] [Related]

  • 7. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
    Markham T, Mullan R, Golden-Mason L, Rogers S, Bresnihan B, Fitzgerald O, Fearon U, Veale DJ.
    J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
    [Abstract] [Full Text] [Related]

  • 8. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
    Goedkoop AY, Kraan MC, Teunissen MB, Picavet DI, de Rie MA, Bos JD, Tak PP.
    Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis.
    El-Domyati M, Moftah NH, Nasif GA, Abdel-Wahab HM, Barakat MT, Abdel-Aziz RT.
    Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):18-26. PubMed ID: 23281693
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
    Lizzul PF, Aphale A, Malaviya R, Sun Y, Masud S, Dombrovskiy V, Gottlieb AB.
    J Invest Dermatol; 2005 Jun; 124(6):1275-83. PubMed ID: 15955104
    [Abstract] [Full Text] [Related]

  • 14. Expression of Bcl-2 family proteins in psoriasis.
    Batinac T, Zamolo G, Hadzisejdić I, Zauhar G, Brumini G, Ruzić A, Persić V.
    Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
    [Abstract] [Full Text] [Related]

  • 15. Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes.
    Tatlican S, Arikok A, Gulbahar O, Eren C, Cevirgen B, Eskioglu F.
    J Dermatolog Treat; 2010 Sep; 21(5):306-10. PubMed ID: 19878038
    [Abstract] [Full Text] [Related]

  • 16. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY, Kraan MC, Picavet DI, de Rie MA, Teunissen MB, Bos JD, Tak PP.
    Arthritis Res Ther; 2004 Sep; 6(4):R326-34. PubMed ID: 15225368
    [Abstract] [Full Text] [Related]

  • 17. Infliximab monotherapy in psoriasis: a case of rapid clinical and histological response.
    Vincek V, Jacob SE, Nassiri M, Herbert LM, Nadji M, Kerdel FA.
    Int J Dermatol; 2004 Apr; 43(4):303-8. PubMed ID: 15090021
    [Abstract] [Full Text] [Related]

  • 18. Combined effect of tumor necrosis factor (TNF)-alpha and heat shock protein (HSP)-70 in reducing apoptotic injury in hypoxia: a cell culture study.
    Goel G, Guo M, Ding J, Dornbos D, Ali A, Shenaq M, Guthikonda M, Ding Y.
    Neurosci Lett; 2010 Oct 15; 483(3):162-6. PubMed ID: 20691248
    [Abstract] [Full Text] [Related]

  • 19. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
    Smit JV, de Jong EM, van Hooijdonk CA, Otero ME, Boezeman JB, van de Kerkhof PC.
    J Am Acad Dermatol; 2004 Aug 15; 51(2):257-64. PubMed ID: 15280845
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.
    Abdou AG, Hanout HM.
    J Cutan Pathol; 2008 May 15; 35(5):445-51. PubMed ID: 18005174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.